Walleye Capital’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $596K | Buy |
+155,609
| New | +$596K | ﹤0.01% | 1012 |
|
|
2025
Q1 | – | Sell |
-13,706
| Closed | -$68.4K | – | 1800 |
|
|
2024
Q4 | $68.4K | Buy |
+13,706
| New | +$68.4K | ﹤0.01% | 1745 |
|
|
2024
Q3 | – | Sell |
-14,168
| Closed | -$46.9K | – | 2452 |
|
|
2024
Q2 | $46.9K | Buy |
+14,168
| New | +$46.9K | ﹤0.01% | 2162 |
|
|
2022
Q2 | – | Sell |
-41,652
| Closed | -$185K | – | 2266 |
|
|
2022
Q1 | $185K | Sell |
41,652
-314,209
| -88% | -$1.4M | ﹤0.01% | 1507 |
|
|
2021
Q4 | $1.42M | Buy |
+355,861
| New | +$1.42M | 0.04% | 415 |
|
|
2021
Q3 | – | Sell |
-179,810
| Closed | -$2.04K | – | 1543 |
|
|
2021
Q2 | $2.04K | Buy |
+179,810
| New | +$2.04K | 0.07% | 228 |
|